Retinal organoids and stem cell therapy for vision restoration: current progress, persistent challenges, and future directions
International Immunopharmacology · 2026-10 · 186 · 117120
DOI: 10.1016/j.intimp.2026.117120 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Bahaa Jaber und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Organoids, Retina, Retinal Pigment Epithelium. Die Arbeit nennt 284 Literaturangaben. Gefördert von: Kashan University of Medical Sciences.
Abstract (Originalsprache)
Vision restoration is a vital yet challenging objective in ophthalmology, as traditional therapies cannot reverse irreversible retinal damage. This issue is of significant concern, considering that millions globally are afflicted by untreatable degenerative conditions such as retinitis pigmentosa (RP) and age-related macular degeneration. Stem cell treatments and retinal organoid (RO) technology have emerged as revolutionary methodologies. ROs derived from pluripotent stem cells (PSCs) autonomously form three-dimensional (3D) laminar structures that mimic the natural human retina, providing exceptional platforms for disease modeling, pharmacological screening, and cellular replacement. Clinical studies indicate that retinal pigment epithelium (RPE) transplantation enhances visual function. In contrast, PSC-derived mesenchymal stem cells (MSCs), retinal progenitor cells (RPCs), and RPE grafts have neuroprotective and regenerative capabilities in preclinical and early-phase trials. Notwithstanding this advancement, several challenges remain, including suboptimal cell survival, insufficient functional synaptic integration, immunological rejection, tumorigenic potential, and the absence of standardized production processes. This article presents three unique contributions, diverging from previous reviews that focus solely on positive outcomes: (1) a comprehensive assessment of advancements and challenges in PSCs, MSCs, RPCs, and RPE; (2) a methodical examination of the disparity between structural engraftment and genuine functional integration; and (3) a cohesive discourse on innovative strategies such as optogenetics, 3D bioprinting, and extracellular vesicle-based therapies. We consolidate recent clinical discoveries, highlight persistent obstacles, and provide a roadmap for the future. Growing evidence suggests that, despite significant obstacles, effective retinal regeneration is gradually becoming a reality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
- Medical Laboratory Techniques department, College of Health and Medical Techniques, University of Al-maarif, Anbar, Iraq.
- College of Pharmacy, Alnoor University, Mosul, Iraq.
- Department of Public Health and Healthcare Management, Rector, Samarkand State Medical University, Samarkand, Uzbekistan.
- Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq.
- Al-Zahrawi University College, Karbala, Iraq.
Förderung
- Kashan University of Medical Sciences
Zitieren
APA
Jaber, B., Abd, M. A., Younis, S. M. D., Rizaev, J., Salih, R. M., Jaber, M. A., Kholboyev, N., & Farajipour, H. (2026). Retinal organoids and stem cell therapy for vision restoration: current progress, persistent challenges, and future directions. International Immunopharmacology, 186, 117120. https://doi.org/10.1016/j.intimp.2026.117120
Vancouver
Jaber B, Abd MA, Younis SMD, Rizaev J, Salih RM, Jaber MA, et al. Retinal organoids and stem cell therapy for vision restoration: current progress, persistent challenges, and future directions. International Immunopharmacology. 2026;186:117120. doi:10.1016/j.intimp.2026.117120
BibTeX
@article{Jaber2026,
author = {Jaber, Bahaa and Abd, Mariam Ayad and Younis, Shahad Mohammed Dhiaa and Rizaev, Jasur and Salih, Rasim M and Jaber, Mohamed Adil and Kholboyev, Norbek and Farajipour, Hasan},
title = {Retinal organoids and stem cell therapy for vision restoration: current progress, persistent challenges, and future directions},
journal = {International Immunopharmacology},
year = {2026},
volume = {186},
pages = {117120},
doi = {10.1016/j.intimp.2026.117120}
}
EUVIMED